Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Non-randomized Study With Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms.

NCT04252573 is registered in ClinicalTrials.gov with Endologix as lead sponsor.

NCT NCT04252573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04252573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Non-randomized Study With Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms.
Lead sponsor
Endologix
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 29, 2020
Completion date
December 31, 2026
Enrollment
13 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

1 paravisceral abdominal aortic aneurysm, 2 juxtarenal abdominal aortic aneurysm, 3 pararenal abdominal aortic aneurysm, 4 complex abdominal aortic aneurysms